Related Experiment Video

Updated: May 6, 2026

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

14.9K

Toward identification of the genetic risk profile for cryptococcal disease in HIV-infected patients

Mihai G Netea1

  • 1Department of Medicine and Nijmegen Institute for Infection, Inflammation and Immunity (N4i), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Mbio
|October 17, 2013
PubMed

Insights

Host genetic variations influence susceptibility to fungal infections. A specific gene polymorphism, FCGR3A 158 F/V, significantly increases the risk of cryptococcal disease in HIV patients, enabling personalized risk assessment.

Area of Science:

  • Medical Mycology
  • Immunogenetics
  • Infectious Diseases

Background:

  • Cryptococcus spp. are significant fungal pathogens causing morbidity and mortality in diverse patient populations.
  • Cryptococcal disease is a leading cause of death in HIV-infected individuals, particularly in sub-Saharan Africa.
  • Host genetic factors are hypothesized to influence susceptibility to cryptococcal infections, as not all at-risk individuals develop the disease.

Purpose of the Study:

  • To investigate the impact of host genetic variation on susceptibility to cryptococcal disease in HIV-infected patients.
  • To provide genetic evidence supporting the role of humoral immunity and FCGR3A-mediated functions in Cryptococcus pathogenesis.
  • To explore the potential for genetic risk stratification in personalized treatment strategies.

Main Methods:

  • Genetic analysis of the FCGR3A 158 F/V polymorphism in HIV-infected patients.
  • Immunological validation of FCGR3A-mediated functions, including antibody-dependent cellular cytotoxicity (ADCC).
  • Correlation of specific genotypes with susceptibility to cryptococcal disease.

Main Results:

  • The FCGR3A 158 F/V polymorphism significantly impacts susceptibility to cryptococcal disease.
  • The 158V allele increases the risk of cryptococcal infections up to 20-fold in homozygous individuals.
  • Humoral immunity and FCGR3A-mediated functions are crucial in the pathogenesis of Cryptococcus infections.

Conclusions:

  • Host genetic variation, specifically the FCGR3A 158 F/V polymorphism, is a critical factor in cryptococcal disease susceptibility among HIV-infected patients.
  • The findings highlight the importance of FCGR3A-mediated immune responses in controlling Cryptococcus infections.
  • This discovery opens avenues for risk stratification and personalized treatment approaches for HIV patients at risk of cryptococcal disease.

More Related Videos

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V311:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

13.2K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.1K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K